Skip to main content

Peptide Profile

Vilon

Lys-Glu · Khavinson immune dipeptide

Vilon is a synthetic dipeptide (Lys-Glu, KE) classified as a Khavinson-class bioregulator originally derived from thymic tissue, proposed to modulate immune function in aging subjects by providing minimal thymic regulatory…

Immune & ThymicNot EvaluatedResearch Only
Used forlongevity
Half-life
Unknown
Routes
subcutaneous, intramuscular

Educational research information — not medical advice. Review primary sources and consult a qualified professional before any decision.

Educational research tools — not medical advice.

Overview

What Vilon is

About Vilon

Synthetic dipeptide Lys-Glu; modulates T-cell and NK cell activity; reduces age-related immune decline; normalizes cytokine production via epigenetic gene regulation

Vilon is a synthetic dipeptide (Lys-Glu, KE) classified as a Khavinson-class bioregulator originally derived from thymic tissue, proposed to modulate immune function in aging subjects by providing minimal thymic regulatory dipeptide signals that support T-lymphocyte activation and immune homeostasis diminished by age-related thymic involution. As the minimal active dipeptide unit of the Khavinson thymic bioregulator class, vilon is proposed to act through amino acid transporter uptake and modulation of intracellular signaling — including sphingomyelin pathway signal transduction in thymocytes — to restore T-cell activation thresholds and proliferative responses in immune cells from elderly subjects. Research has characterized natural and synthetic thymic peptides including vilon as therapeutic candidates for immune dysfunction, and experimental work has demonstrated that short Khavinson-class peptides modulate thymocyte blast transformation and sphingomyelin pathway signaling in immune cell preparations. Vilon has no FDA approval; evidence derives from Khavinson-series Russian preclinical and observational studies, and it has no regulatory approval in any major Western jurisdiction.

Vilon Benefits & Research Areas

immune modulationanti-agingimmune restorationLongevity

Research Signals

Population research notes

50+

These signals reflect research interest areas, not treatment indications.

The Research

What the evidence says about Vilon

Research Evidence

based on 1 study · dated evidence base — most recent 2002

Regulatory Status

Availability Status
Research Only
FDA Status
Not Evaluated

Russian dipeptide bioregulator (Lys-Glu) from Khavinson Institute. Immunomodulatory and longevity research. Not FDA-approved. Not on any FDA list. Research chemical in US.

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Research Sources

1 source cited · 1 weak

1 Animal

  • Comparative study of the effects of vilon, epithalon, and cortagen on thymocyte proliferation and sphingomyelinase activity

    Bulletin of Experimental Biology and Medicine · 2002

    Research in mouse thymocyte cultures found that vilon produced the most potent comitogenic stimulation of thymocyte proliferation and sphingomyelinase activity compared with epithalon and cortagen, providing mechanistic evidence for its thymopoiesis-promoting activity and relevance to immune restoration in aging.

    AnimalWeakPMID 12420072

Vilon Side Effects & Safety Considerations

Research-use compound with limited human data. Evidence strength varies — see the Evidence section.

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.

Certificates of Analysis

2 COAs on record for Vilon

PeptideBase reports these lab-published figures and does not itself test, endorse, or certify any product. Confirmed by lab results were matched against the issuing laboratory's own records — either the lab served the document, or its own hosted copy matches ours byte for byte. For every other result the badge states what is known about the lab: that it can be checked and no result is recorded yet, that it can't be checked, or that we have not reviewed it.

PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Frequently Asked Questions — Vilon

Vilon is a synthetic dipeptide (Lys-Glu, KE) classified as a Khavinson-class bioregulator originally derived from thymic tissue, proposed to modulate immune function in aging subjects by providing minimal thymic regulatory dipeptide signals that support T-lymphocyte activation and immune homeostasis diminished by age-related thymic involution. As the minimal active dipeptide unit of the Khavinson thymic bioregulator class, vilon is proposed to act through amino acid transporter uptake and modulation of intracellular signaling — including sphingomyelin pathway signal transduction in thymocytes — to restore T-cell activation thresholds and proliferative responses in immune cells from elderly subjects.

immune modulation, anti-aging, immune restoration, Longevity.

Research on Vilon primarily documents effects related to immune modulation and anti-aging and immune restoration and Longevity. These are areas covered in preclinical and clinical literature — individual response varies and effects depend on context of use.

For Vilon, its FDA status is not evaluated by the FDA, and it is designated for research use only. Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

2 providers in the directory currently offer Vilon.

Across 12 research vendors tracked on PeptideBase, Vilon has a median price of about $2.88 per mg, typically ranging $2.66–$3.01 per mg. This reflects research-use vendor pricing, not clinical or prescription costs.

Access

How to get Vilon

Market Pricing

12 vendors
$2.66/mgBudget
$2.88/mgMedian
$3.01/mgPremium
$2.66
$2.88
$3.01

Price per mg varies by quantity, vendor type, and formulation. Research use only.

Data verified August 2026 · Vilon price intelligence

Where to buy Vilon

2 providers
1 Clinic1 Online Vendor3 in stock

Questions to ask your provider

Stay updated on Vilon providers

New providers added weekly — delivered to your inbox.

Weekly research digest. No spam. Unsubscribe anytime.

Last updated

Cite this page

Data last updated August 26, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Vilon — Per-mg Price Benchmark. Retrieved September 11, 2026, from https://peptidebase.io/peptides/vilon

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.